Anna Protopapas, a director at Mersana Therapeutics Inc . (NASDAQ:MRSN), recently reported a sale of company stock, according to a filing with the Securities and Exchange Commission. On January 15, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback